Skip to content
Search

Latest Stories

Submit Guest Post

UK’s Strathclyde Joins Indian Partners To Study Challenges Created By Urban Living

THE Institute of Future Cities at UK’s University of Strathclyde signed agreements with the University of Calcutta; the department of environment, Government of West Bengal; and Bengal Chamber of Commerce and Industry (BCC&I) at the Bengal Global Business Summit last week to look at the opportunities and challenges created by urban living.

Together the partners will identify barriers and solutions to sustainable economic growth; resilience of critical urban systems and infrastructure; environmental sustainability; and health, wellbeing and quality of life for the citizens of Kolkata and West Bengal, University of Strathclyde said in a release.


The five-year agreements will see the exchange of ideas, data and expertise and the creation of joint funding bids for research and consultancy, scholarships, a joint masters programme, joint workshops and conferences and reciprocal visits.

In the first year of the agreement the partners will work together to create projects on the development of low-carbon energy for Kolkata, strategies for future city development, optimisation of urban systems such as transport and health, and pollution and noise reduction. Improving air quality has been identified by the partners as a key priority.

Strathclyde’s work in Kolkata is financed jointly by the Scottish government and the UK government’s global challenges research fund.

Cities are home to an ever-growing proportion of the world’s population, putting pressure on transport infrastructure, the environment and quality of life.

Kolkata, with more than 14 million citizens, is the third-most populous urban area in India after Delhi and Mumbai and is among the largest and most populous cities on Earth.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

AstraZeneca

AstraZeneca chief executive Pascal Soriot says the company has the science, pipeline and team to deliver its long-term growth ambitions

Getty Images

AstraZeneca targets $80bn revenue by 2030 with $1.5bn savings and pipeline investment

  • AstraZeneca expects its restructuring programme to generate $1.5bn in annualised savings by 2029, with most of the money reinvested in research and development.
  • The plan could incur up to $2bn in one-off restructuring costs, although the company expects its overall workforce to continue growing.
  • Third-quarter revenue rose 7 per cent to $16.21bn, while oncology sales increased 17 per cent to $7.77bn.

AstraZeneca has unveiled plans to generate around $1.5bn in annual savings through a three-year restructuring programme, as chief executive Pascal Soriot shifts the focus back to growth and investment in its drug pipeline.

The British-based pharmaceutical group said its Reshaping for Sustainable Growth programme would redirect resources towards research and development, particularly its pipeline of more than 180 projects and emerging technologies.

Keep ReadingShow less